carbon tetrachloride has been researched along with artesunic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Chen, Y; Fang, B; Lai, L; Lei, J; Li, X; Song, X; Tian, X; Zhang, X | 1 |
| Bi, YH; Chen, YX; Fan, YM; Han, DW; Ji, C; Lai, LN; Li, XJ; Meng, L; Tian, XX; Wang, LM; Zhang, HY; Zhao, ZF | 1 |
2 other study(ies) available for carbon tetrachloride and artesunic acid
| Article | Year |
|---|---|
Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-κB signaling pathway in rats.
Topics: Animals; Artemisinins; Artesunate; Body Weight; Carbon Tetrachloride; Drugs, Chinese Herbal; Endotoxins; Liver; Liver Cirrhosis, Experimental; NF-kappa B; Organ Size; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4 | 2015 |
Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Artesunate; Bacteria; Bacterial Translocation; Carbon Tetrachloride; Cytokines; Disease Progression; Dysbiosis; Feces; Gastrointestinal Microbiome; Inflammation Mediators; Intestinal Mucosa; Intestines; Liver Cirrhosis, Experimental; Male; Rats, Sprague-Dawley; Time Factors | 2016 |